Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal Tumors

NCT07614841 is registered in ClinicalTrials.gov with First Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT07614841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07614841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal Tumors
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 31, 2025
Enrollment
328 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal stromal tumors (gists)